Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Cynata Therapeutics Limited

Investor presentation - Cynata Therapeutics Limited

ASX:CYP

Cynata Therapeutics Limited

Health

Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. The company intends to commercialise the use of MSC therapies worldwide to address a wide range of medical issues.

Read more

Market Cap

$96.71m

Price at Close

$0.675

4w avg. Volume

218.97k

4w avg. Turnover

$155.19k

Announcements
announcementt+2 movementdate
  • Cleansing Notice

    Issued Capital

  • -3.57%

    20 Jan 2021

-3.57%

20 Jan 2021
  • Appendix 2A

    Issued Capital

  • -3.57%

    20 Jan 2021

-3.57%

20 Jan 2021
  • Completion of Entitlement Offer and Shortfall Placement

    Issued Capital · Market sensitive

  • +0.72%

    17 Jan 2021

+0.72%

17 Jan 2021
  • Entitlement Offer Closing Date Reminder

    Issued Capital

  • -3.40%

    10 Jan 2021

-3.40%

10 Jan 2021
  • Cleansing Notice

    Issued Capital

  • -0.72%

    30 Dec 2020

-0.72%

30 Dec 2020
  • Appendix 2A

    Issued Capital

  • -0.72%

    30 Dec 2020

-0.72%

30 Dec 2020
  • 2020 Review and Outlook

    Progress Report

  • -2.14%

    29 Dec 2020

-2.14%

29 Dec 2020
  • Becoming a substantial holder

    Shareholder Details

  • -2.14%

    29 Dec 2020

-2.14%

29 Dec 2020
  • Cleansing Notice

    Issued Capital

  • +2.19%

    23 Dec 2020

+2.19%

23 Dec 2020
  • Appendix 2A

    Issued Capital

  • +2.19%

    23 Dec 2020

+2.19%

23 Dec 2020
Market Data

Current Price

$0.675

52WK HIGH

$1.2

52WK LOW

$0.58

1YR RETURN

-40.79%

1YR RETURN VS. SECTOR

-79.48%

90 DAY RETURN

-17.18%

ASX RANK

903

/2,048

SECTOR RANK

80

/168

SHARES OUTSTANDING

143.28m
ASX:CYP

Cynata Therapeutics Limited

Health

Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. The company intends to commercialise the use of MSC therapies worldwide to address a wide range of medical issues.

Read more

Market Cap

$96.71m

Price at Close

$0.675

4w avg. Volume

218.97k

4w avg. Turnover

$155.19k

ASX:CYP is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.